CeraVx

About CeraVx

CeraVx B.V. is a privately held global biotechnology company developing and commercializing a proprietary drug delivery platform based on a ceramic micro-needle array patches (CeraMAPs™). The CeraMaps technology was initially developed at the University of Twente, MESA+, Institute for Nanotechnology, The Netherlands. The company is focussing on prophylactic and therapeutic vaccines. In 2024 CeraVx acquired the propietary micro-needle technology from MLT.

Keywords

• Biopartner
• Covid-19
• Dermal Drug Delivery
• Dna Vaccines
• Feasibility Services
• Hpv
• Infectious Diseases
• Influenza
• Leiden Bio Science Park
• Mrna Nano Particles
• Ngo
• Peptide Delivery
• Prophylactic Vaccines
• Skin Patches
• Therapeutic Vaccines
• Vaccine Delivery
• Vlp-Vaccine Delivery

Address

• Headquarters

  Leiden BioScience Park, BioPartner 4, Unit 43582333CG LeidenZuid-Holland, Netherlands

Team by function

Based on 8 public job profiles as of 3 September 2026.

• Executive / C-Suite3
• Research / R&D3
• Consulting / Advisory1
• Operations1